N. Yonetani et al., Primary mediastinal large B-cell lymphoma: A comparative study with nodular sclerosis-type Hodgkin's disease, INT J HEMAT, 74(2), 2001, pp. 178-185
The clinicopathological features of 10 patients with primary mediastinal la
rge B-cell lymphoma (PMLBCL) are described. The patients were aged 19 to 63
years, with a median age of 25.5 years. There were 5 men and 5 women. All
patients presented with chest symptoms, and 6 presented with superior vena
cava syndrome. Nine patients had bulky mediastinal tumors. The disease was
confined within the thorax and contiguous lymph nodes, although multiple li
ver tumors were observed in 1 patient. Laboratory findings included high la
ctate dehydrogenase levels and elevated C-reactive protein levels. The solu
ble interleukin 2-receptor level was high in 6 patients tested. A comparati
ve study of PMLBCL and nodular sclerosis-type 1-Hodgkin's disease (NS-HD) w
ith a mediastinal mass revealed substantial overlap in clinical features. H
istopathological examination of biopsy specimens of PMLBCL revealed cluster
s of CD20(+) large cells; however, CD30(+) Hodgkin/Reed-Sternberg-like cell
s were occasionally seen, raising the potential to misdiagnose PMLBCL as NS
-HD. The patients with PMLBCL were treated with CHOP (cyclophosphamide, dox
orubicin, vincristine, and prednisolone), biweekly CHOP, or MACOP-B (methot
rexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleom
ycin) regimen, and 6 received consolidation radiotherapy to the involved fi
eld. With the exception of 1 patient who was primarily refractory to therap
y, 9 patients (90%) achieved complete response and 7 (70%) remain in contin
uous remission with a mean follow-up of 24 months. (C) 2001 The Japanese So
ciety of Hematology.